Status:
COMPLETED
Beta-2 Microglobulin and Serum Cytokines x HAART
Lead Sponsor:
UPECLIN HC FM Botucatu Unesp
Collaborating Sponsors:
Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil
Conditions:
HIV Patients
Eligibility:
All Genders
18-80 years
Brief Summary
Cross-sectional study to assess the behavior of Beta-2 microglobulin and serum cytokines TNF-α, IFN-γ, IL-2, IL-4 and IL-10 as indicators of highly active antiretroviral therapy (HAART) failure.
Detailed Description
Objective: To assess the behavior of Beta-2 microglobulin and serum cytokines TNF-α, IFN-γ, IL-2, IL-4 and IL-10 as indicators of highly active antiretroviral therapy (HAART) failure Design: Cross-sec...
Eligibility Criteria
Inclusion
- HIV-1-infected individuals
- Over 18 years old
- Sign the "written consent form" (WCF)
Exclusion
- Do not presenting other immunosuppression causes, such as neoplasias, transplantations
- Do not presenting treatment by immunosuppressive substances
- Do not presenting auto-immune diseases
- Not be using any type of immunostimulating substances
- Not at any time of gestation
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT00831207
Start Date
August 1 2004
End Date
December 1 2008
Last Update
January 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculdade de Medicina de Botucatu - UNESP
Botucatu, São Paulo, Brazil, 18618-970